MedTrace Logo

Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility

NCT03250988 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-10-09

No results posted yet for this study

Summary

The purpose of this study is to improve spasticity diagnosis through exploration of potential new diagnostic markers for spasticity that can assist in diagnosis and referral.

Conditions

  • Spasticity, Muscle
  • Muscular Diseases
  • Musculoskeletal Disease
  • Muscle Hypertonia
  • Muscle Spasticity
  • Neuromuscular Manifestations
  • Signs and Symptoms
  • Nervous System Diseases
  • Neurologic Manifestations

Interventions

DIAGNOSTIC_TEST

Neurological Examination

The subject will undergo elements of the neurological examination during which the movement disorders neurologist will look specifically for the presence of spasticity. If spasticity is found to be present during the examination, the neurologist will rate the severity of the spasticity in all affected limbs and record whether they would recommend treatment for spasticity, and if so, which treatment(s) they believe would be beneficial for the subject.

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • David Charles, M.D. · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-30
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03250988 on ClinicalTrials.gov